# Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

> **NCT00798317** · PHASE3 · COMPLETED · sponsor: **ThromboGenics** · enrollment: 326 (actual)

## Conditions studied

- Vitreomacular Adhesion

## Interventions

- **DRUG:** Ocriplasmin 125µg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00798317
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798317, "Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT00798317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*